KBC Group NV Has $19.52 Million Stock Position in CVS Health Corporation (NYSE:CVS)

KBC Group NV lessened its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 82.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 288,156 shares of the pharmacy operator's stock after selling 1,367,334 shares during the period. KBC Group NV's holdings in CVS Health were worth $19,522,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Dodge & Cox grew its stake in CVS Health by 11.2% during the 4th quarter. Dodge & Cox now owns 70,105,899 shares of the pharmacy operator's stock valued at $3,147,054,000 after acquiring an additional 7,075,209 shares in the last quarter. Capital World Investors boosted its holdings in shares of CVS Health by 26.6% during the fourth quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator's stock worth $2,739,927,000 after purchasing an additional 12,819,148 shares during the period. Geode Capital Management LLC grew its position in CVS Health by 2.6% during the fourth quarter. Geode Capital Management LLC now owns 27,051,540 shares of the pharmacy operator's stock valued at $1,211,582,000 after purchasing an additional 689,867 shares in the last quarter. Capital International Investors increased its stake in CVS Health by 4.8% in the 4th quarter. Capital International Investors now owns 26,666,401 shares of the pharmacy operator's stock valued at $1,196,989,000 after buying an additional 1,212,126 shares during the period. Finally, Pzena Investment Management LLC lifted its position in CVS Health by 49.3% in the 4th quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator's stock worth $880,319,000 after buying an additional 6,475,271 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. Morgan Stanley restated an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. Mizuho boosted their target price on CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Jefferies Financial Group raised their price target on CVS Health from $74.00 to $80.00 and gave the stock a "buy" rating in a research note on Monday. Truist Financial lifted their price target on CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a report on Monday, May 12th. Finally, Barclays set a $79.00 price objective on CVS Health and gave the stock an "overweight" rating in a report on Monday, June 2nd. Two investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $75.06.

CVS Health Stock Performance

CVS traded up $0.87 during trading on Thursday, hitting $67.47. The stock had a trading volume of 3,770,280 shares, compared to its average volume of 10,811,120. The firm has a market cap of $85.35 billion, a PE ratio of 16.10, a P/E/G ratio of 1.00 and a beta of 0.57. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $72.51. The company has a 50 day simple moving average of $65.03 and a 200-day simple moving average of $61.17.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.63. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The business had revenue of $94.59 billion during the quarter, compared to analysts' expectations of $93.07 billion. During the same quarter in the previous year, the firm earned $1.31 EPS. The firm's revenue was up 7.0% compared to the same quarter last year. Analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

Insider Buying and Selling at CVS Health

In related news, Director Guy P. Sansone bought 1,570 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The shares were acquired at an average price of $63.70 per share, with a total value of $100,009.00. Following the completion of the transaction, the director owned 12,007 shares of the company's stock, valued at $764,845.90. The trade was a 15.04% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.22% of the company's stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.